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Summary.-Recent data on extrapulmonary colony formation after heparin admini-
stration are inconclusive. A systematic study of this topic was undertaken with 4
experimental tumour systems and 2 distinct periods of reduced clotting capacity in
rats and mice. I.v. injection of various numbers of tumour cells into i.p. heparinized
animals leads to:
(1) Significant reduction in the number of lung colonies. The effect after 9 h anti-
coagulation is equal to or probably greater than after 2 h.
(2) The reduction in the number of lung colonies caused by heparin is independent
of the number of cells injected.
(3) The number ofextrapulmonary extrathoracic colonies is significantly increased
by heparin in 3 of the 4 tumour systems.
(4) The number of extrapulmonary intrathoracic colonies is probably unaffected.
(5) The increase in extrapulmonary extrathoracic colony formation is not related
to the degree of reduction in lung colonies.
These data lead to the conclusion that the capacity of the lung capillaries to trap
tumour cells can be decreased by heparin-induced alterations in fibrin formation.
This results in a lodgement of tumour cells throughout the body which is far more
pronounced than in animals with normal clotting capacity.
IT HAS been shown that anticoagulants
influence the spread of cancer cells through
the body, at least in experimental tumour
systems. Many authors have reported a
reduction in lung colonies after i.v.
injection of tumour cells into animals
which have been treated by various anti-
coagulants such as heparin, coumarin
derivatives, and ancrod. Treatment with
coumarins also reduces the number of
lung metastases in animals bearing an s.c.
transplanted tumour (Hilgard and
Thornes, 1976; Hilgard et al., 1977). It
seems logical to explain these findings by
postulating reduced lodgement of circulat-
ing tumour cells in the lung. This raises
the question whether cells which do not
lodge in the lungs are distributed through
the rest of the body and cause tumour
growth elsewhere. A limited number of
reports in the literature claim an increase
in secondary tumours outside the lungs as
a result of anticoagulation (Lawrence,
Moore and Bernstein, 1953; Boeryd, 1965;
Hagmar and Boeryd, 1969). Many others,
however, could not find such an increase.
Reviewing them (in Table V) a number of
differences appear to exist between the
tumours used, making comparison diffi-
cult. The present study was therefore
undertaken as a systematic investigation
of the effect of heparin on the distribution
of i.v. introduced cells of 4 known meta-
stasizing tumour systems in rats and mice.
MATERIALS AND METHODS
Tumour systems.-Four syngeneic trans-
plantable tumour systems were employed,
which metastasize in a reproducible way
following s.c. or i.m. injection:B. MAAT
(1) the Lewis lung (3LL) carcinoma was
obtained from Professor Garattini, Istituto
Mario Negri, in 1970, and it is maintained by
regular s.c. transplantation into inbred
C57BL/Rij mice every 14 days;
(2) The B16 melanoma, obtained from Dr
Atassi, Institut Jules Bordet, Brussels, is
maintained in the same way as 3LL;
(3) WAG/Rij Schwannoma arose spontane-
ously in the WAG/Rij rat in 1974, and is
serially transplanted s.c. into syngeneic
WAG/Rij rats. For this study, the 19th
passage has been used. It metastasizes spon-
taneously to the lungs;
(4) ETC-5 astrocytoma was chemically in-
duced in Sprague-Dawley rats in 1974. It is
transplanted every 3 weeks, and s.c. implan-
tation is followed by metastases to the lungs,
liver, kidney and sometimes adrenals. The
18th passage has been used.
Cell suspensions.-To obtain single-cell
suspensions of a high degree of viability,
enzymatic digestion with trypsin was used.
Tumour-bearing animals were killed by
breathing CO2. The tumour was removed
and all necrotic material and blood clots
were cut away. After weighing, this cleaned
tumour material was minced in a small
amount of sterile PBS (Ca++ and Mg++ free,
pH 7-4, osmolarity 300 mOs/l) and exposed
to 10 ml trypsin solution (trypsin NBCO
0.25% in Sol A according to Puck, Marcus
and Cieciura, 1956) per gram tissue. The
mixture was allowed to stand for 30 min at
room temperature with occasional shaking.
The supernatant was filtered through a 4-ply
nylon gauze and discarded. Microscopically,
this material consists almost entirely of dead
tumour cells and debris. The remaining tissue
fragments were then resuspended in fresh
trypsin solution in the same proportion and
agitated for 60 min at room temperature in
a sterile trypsinization vessel on a magnetic
stirrer. After passage through a nylon filter
(-50 ,um opening) the cell suspension was
centrifuged at 200 g for 15 min at 0°C.
The cell pellet was then resuspended in
sterile ice-cold PBS, after the addition of
0-1 ml foetal calf serum per 10 ml trypsin
solution to inhibit the trypsin. The centri-
fugation procedure was repeated twice. All
subsequent handlings were performed at
0OC.
This method of preparation usually yields
10-15 x 106 viable single cells per gram of
tissue, for each of the 4 tumours, as deter-
mined by eosin-exclusion test. The final
suspension contains 95-98% viable cells.
Anticoagulation regimens.-In order to
achieve different periods of anticoagulation,
two types of heparin were used throughout
the experiments. Sodium heparin (Throm-
boliquine, Organon) injected i.p. at a dose of
3000 i.u. (30 mg)/kg mouse and 1000 i.u.
(10 mg)/kg rat produced a decreased clotting
capacity lasting about 3-1 h, as determined
by the Normotest assay (Nyegaard, Oslo).
Sodium heparin (Heparine Novo Lente,
NOVO) injected i.p. at a dose of 15,000 i.u./
kg mouse and 5,000 i.u./kg rat kept the
clotting capacity below 50% of normal for a
period of about 10 h.
Experimental design.-Different concentra-
tions of single cell suspensions prepared as
above, for all 4 tumour systems, were
injected into the tail veins of prewarmed
mice or rats. The volume ofthe inoculum was
always 0-5 ml, for both mice and rats. To
ensure an adequately reduced blood co-
agulability at the time of administration of
tumour cells, the heparin was injected i.p. 1 h
before. The animals were allowed to survive
for varying periods of time after cell inocula-
tion, depending on the growth rate of the
tumour, usually between 17 and 25 days.
They were then killed by breathing C02,
skinned, and thoroughly examined macro-
scopically. All macroscopic tumour nodules
throughout the body, including relevant
organs such as liver, spleen, kidneys, adrenals
sternum, heart, brain and various lymph
nodes, were taken out for histological exa-
mination. The lungs were removed and fixed
in Bouin's-solution. After a few days, lung
colonies could be counted macroscopically.
Scoring system.-Lung colonies were count-
ed with the aid of a magnifying lens; colonies
measuring lessthan 0-2 mm were not counted.
Extrapulmonary tumour deposits were divi-
ded into two groups, intra- and extrathoracic.
The first group (EIC) were restricted to the
inner walls ofthe thorax includingdiaphragm,
pleural membranes, heart with pericardium
and mediastinal area. The second group
(EEC) occurred at all other sites in the body,
including the outer walls of the thorax and
excluding the diaphragm.
RESULTS
The degree of hypocoagulation after
heparin administration as measured by
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lungs after heparin-induced anticoagula-
tion. Table II shows the results ofheparin
treatment for the B-16 melanoma. In this
case the number of lung colonies was also
markedly reduced by a factor ranging
from 2-3 to 8-7. The number of EICs
remained unaffected in the group anti-
coagulated for 2 h, and only a few colonies
were found when 9 h anticoagulation was
induced. The number of EECs was
increased, as was the case in the 3LL
system. Again, hypocoagulability lasting o 2 4 6 8 10 12 2 or 9 h encourages extrapulmonary
time after injection (h) tumour colony formation.
Percentage clotting capacity after i.p. The results of the experiments with the
ijection of heparin as determined by 2 rat systems are in Table III
'ormotest assay. Open symbols, rat; presented
losed symbols, mouse; circles, Thromboli- for the Schwannoma and in Table IV
uine; squares, Heparin NOVO lente. for the astrocytoma. As can be seen, the
Schwannoma behaves in the same man-
Normotest assay is represented in ner as the two mouse-tumour models
'igure. investigated; the number of EECs, in
ble I shows the average numbers of particular, is significantly increased after
colonies in the 3LL system after heparin pretreatment in 3 of the 4 cell
rin treatment and in normal animals. concentrations. The astrocytoma, how-
luctionrangingfrom 13-4 to morethan ever, shows no increase in EECs. The
mes was found. The average number reduction in the number of lung colonies
ECs per animal is decreased to varying ranged from 4- to 43-fold in the Schwan-
es after heparin pretreatment. A noma model and 3- to more than 12-fold
Rcant increase in EECs is observed in the astrocytoma. The extrapulmonary
ie heparin-pretreated groups. Both intrathoracic spread was not influenced in
the average numlers of colonies per
animal and the percentages of animals
showing EECs indicate that significantly
more tumour growth occurs outside the
these systems.
In general, the mouse data are similar
to the rat data. The sites of extrathoracic
colonies were similar in rat and mouse, and
TABLE I.-Average Numbers (± s.e.) of Lung Colonies, Extrapulmonary Intrathoracic
Colonies (EIC) and Extrapulmonary Extrathoracic Colonies (EEC) after i.v. Injection
of 3LL Tumour Cells into C57BL/Rij S Mice 1h after Injection of Heparin. The
Percentage of Mice with EIC or EEC is in Parentheses. Groups of 8-12 Mice
Untreated
19-6 ± 2-3
37-5 ± 3-7
100
6-0 2-1 (72)
6-9 ± 1-6 (75)
26-3 ± 1-3 (83)
03 ± 0-1 (27)
0 (0)
0 (0)
Period of impaired coagulation
2h 9h
1-0 ± 0*2
2-8 0.5
5-3 ± 1-0
0-2 ± 0-1 (16)
6-7 ± 2-3 (70)
4-1 1-3 (70)
2-5 ± 0-5 (66)
1-4 ± 0-2 (60)
1-2 ± 0.5 (50)
1-1 -4- 0-5
1-3 ± 0-4
1.9 ± 0.5
2-1 ± 0-5 (50)
3-8 ± 0 9 (75)
0-6 ± 0*5 (11)
0-9 ± 0-2 (30)
2-6 ± 0-5 (88)
0-2 0-1 (22)
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TABLE II.-Average Numbers (± s.e.) of Lung Colonies, Extrapulmonary Intrathoracic
Colonies (EIC) and Extrapulmonary Extrathoracic Colonies (EEC) after i.v. Injection
of B16 Tumour Cells 1 h after Injection of Heparin. The Percentage ofMlice with
EIC or EEC is given in Parentheses. Groups of 8-12 Mice
Perio)d of impaired coagulati'on
Unitreate(d
6-5 2- 08
22-0 ± 2-1
47-7 -t 0*5
0
0
0
0
0
0
2 h
1-4 -- 05
2-6 0-.5
5.5 + 0 3
0
0
0
0
0-3 1I (20)
0(1 - 0-1 (10)
9 h
2-8 + 0 7
4i6 ± 0'9
9-5 1-6
0.1 0-1 (10)
1-2 - 0 4 (10)
0
0
8-3 - 6-6 (20)
0
TABLE III. Average Numbers (t s.e.) of Lung Colonies, Extraplutlmonary Intrathoracic
Colonies (EIC) and Extrapulmonary Extrathoracic Colonies (EEC) after i.v. Injection
of JI'AG/Rij Schwannoma Cells 1 h after Injection of Heparin. In Parentheses, the
Number of Rats with EIC or EEC is Indicated as a Percentage. Groups of 8-12 Rats
Period of impaired coagulation
Untireated
26-0 4-4
35-3 ± 7 0
114-9 ± 15-5
762 21-8
13 -0 6-5 (20)
2-0 1-,3 (20)
4-.5 2-4 (37)
0-3 ± 0-2 (20)
0-1 4 0-1 (10)
0-1 (-1 (20)
0
2 h
4-3 -1_ 3
4 0 J-- 0-6
31-0 - 4-8
218 31-8
4-5 4-4 (30)
2-6 ± 1-2 (22)
0
0-4 t- 0-2 (20)
0
0-1 -1- 0-1 (22)
0
0-14 03 (40)
9 h
0-6 -- 0-2
4-1 + 0-8
14-4 - 1-2
106 4- 12-0
0
> 4 (66)*
12 - 1 0 (30)
0
() 1 --1* (22)
0 3t (33)
0
2-5 ± 1-7 (37)
* 1 rat showe(d multiple colonies.
t 2 rats showe(d multiple colonies.
independent of the number of cells
injected. They were mainly found in the
muscles of all four limbs, the abdominal
wall and intercostal muscles. To a lesser
degree, tumour growth was found in
parenchymal organs such as kidneys, liver
and adrenals. The extrapulmonary intra-
thoracic colonies were located mainly in
the mediastinum and at the pleural
membranes, though the heart was also
frequently involved. Tumour nodules were
never found in the brain.
1)1DSCUSSION
The effect of sodium heparin on the
dissemination of i.v. injected tumour cells
has been described by a limited number of
authors. Their experiments, when com-
parable, appear to be contradictory, at
least in respect of extrapulmonary growth
of tumour cells (see Table V).
Several of these reports (Fisher and
Fisher, 1961; Clifton and Agostino, 1962,
1963; Retik etal., 1962; Wood, Holyokeand
Yardley, 1956;WoodYardleyand Holyoke,
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TABLE IV. Average Numbers (± s.e.) of Lung Colonies, Extrapulmonary Intrathoracic
Colonies (EIC) and Extrapulmonary Extrathoracic Colonies (EEC) after i.v. Injec-
tion of Astrocytoma Cells 1 h after Injection ofHeparin. In Parentheses, the Numbers
of Rats with EEC or EICs are Indicated as a Percentage. Groups of 8-12 Rats
Period of impairedl coagulation
Site of
coloinies No. cells Untreated 2 h 9 h
Lung 104 2-0± 05 0-6± 05 0
6 x 104 11-6 1-5 2-6 0 9 1-3 0-6
4 x 105 105 5-8 35-2 6-3 8-6 1-9
EIC
EEC
104
6 x 104
4 x 105
104
6 x 104
4 x 105
0
1.1 ± 1-0 (10)
.09 ± 1-8 (90)
0
0
0-2 ± 0-1 (20)
0
2-5 ± 2-0 (20)
21-1 -1 4-3 (70)
o
0
0
1-8 ± 0-8 (30)
1-4 - 1-2 (30)
0
0
0 3 - 0 1 (30)
1956; Boeryd, 1966; Hagmar, 1969; Suem-
asu and Ishikawa, 1970), dealing with i.v.
injection of various tumour cell systems,
reveal a more or less pronounced decrease
in lung colonies, but none report on any
extrapulmonary colonies. The reason for
this might be, of course, that they escaped
observation, but it seems more likely that
redistribution oftumour cells did not occur
in their systems and under their experi-
mental conditions. Lawrence et al. (1953),
however, found an increase in the number
of rabbits with extrapulmonary growth,
after treating them with heparin and i.v.
tumour cells. Boeryd (1965, 1966) and
Hagmar and Boeryd (1969), using two
different mouse tumour systems, also
found a redistribution of i.v. introduced
tumour cells to extrapulmonary spaces
after treatment with heparin. On the
other hand, Wood (1964) observed a
decrease in extrapulmonary tumour nod-
ules after V2 ascites tumour-cell injection
into plasmin-treated rabbits.
It should be noted that all 4 tumour
systems that we tested showed a signifi-
cant reduction in the number of lung
colonies. The effect after 9 h anticoagula-
tion is equal to (B16) or not much greater
(3LL, astrocytoma and Schwannoma) than
after 2 h. This indicates that the final
number of tumour cells which are lodged
in the lung capillaries is determined more
by the haematological situation at the
time of injection and during the following
2 h than at any later time. This is con-
firmed by cell-labelling studies (Brown,
1973). The relative reduction in the
numberoflung colonies, caused byheparin,
is independent of the number of cells
injected. Even very large numbers of
tumour cells (5 x 106) show the same
effects after injection.
In 3 of the 4 tested tumour systems,
we observe that the numnber of EECs is
significantly increased. Moreover, this
increase is not related to the number of
cells injected. EIC formation was un-
affected by heparin treatment. Critical
examination of these results supports the
idea of redistribution of tumour cells after
i.v. injection into heparinized recipients.
The mechanism of lodgement of tumour
cells in blood capillaries is closely related
to blood coagulation factors. Free circulat-
ing cancer cells adhere to the capillary
vascular endothelium. In experimental
systems where tumour cells are introduced
i.v., this is followed by rapid formation ofa
coagulum, which consists of fibrin and
platelets, around the tumour cells (Chew
and Wallace, 1976; Warren, 1976). After
the adjacent capillary wall has been made
passable, the tumour cell penetrates into
the perivascular tissues where metastatic
growth occurs. Since heparin is a potent
inhibitor of in vivo fibrin formation, the
sticking of tumour cells to the vascular
endothelium can be largely prevented by
heparin. The majority of tumour cells
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injected i.v. into an animal with normal
clotting capacity are thought to be trapped
in the first capillary bed that is en-
countered (in the lung). In heparinized
animals, this trapping mechanism is
apparently no longer effective, since a
significant increase in extrapulmonary
growth is observed in those animals. The
fact that the increase in number of such
extrapulmonary deposits shows no relation
to the reduction in lung colonies is not
fully understood. Since the cells which are
responsible for the extrapulmonary growth
might circulate during a longer period of
time, a possible explanation could be that
the host defence mechanisms have more
opportunity to destroy them. On the other
hand many cells may disappear from the
circulation due to mechanical destruction,
as described by Hewitt and Blake (1975).
Furthermore one might question why
only extrathoracic growth is enhanced by
heparin treatment, and intrathoracic
extrapulmonary growth remains un-
affected. A possible explanation is that
the EEC formation is a result of only
haematogenous spreadwhereas EIC spread
could follow lymphatic pathways. The
intra-aortic injection of 51Cr-labelled
Walker tumour cells into SIV-S0 rats
resulted in the appearance of labelled
tumour cells in the thoracic duct (Hilgard
et al., 1972). Since heparin is not effective
in lymphatics, the spread of tumour cells
in lymphatic vessels may similarly remain
unaffected, thus explaining the absence of
any increase in extrapulmonary intra-
thoracic growth.
This study has shown a significant
increase in EEC formation in heparinized
animals. It should be stressed that this
increase was not dependent on the number
of tumour cells injected. Even small
numbers of cells, producing small numbers
of lung colonies, are still able to give rise
to extrapulmonary growth to the same
degree as is found when large numbers of
cells are injected. This finding supports the
idea of impaired coagulation-associated
lodging rather than the hypothesis of
dose-dependent overflow.
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